Jilin Ginseng Academy, Changchun University of Chinese Medicine, Changchun, 130117, China.
J Ethnopharmacol. 2020 Jan 30;247:112213. doi: 10.1016/j.jep.2019.112213. Epub 2019 Sep 25.
Historical literature and pharmacological studies demonstrate that ginseng, one of the most popular herbal medicines in China, holds potential benefits for Parkinson's disease (PD).
Studies in Drosophila melanogaster (Dm) have highlighted mitochondrial dysfunction upon loss of PTEN-induced putative kinase 1 (PINK1) as a central mechanism of PD pathogenesis. Using PINK1 mutant Dm, we aimed to explore the therapeutic action of ginseng total protein (GTP) on PD and provide in-depth scientific interpretation about the traditional efficacy of ginseng.
We first used gel chromatography to purify GTP and confirmed its molecular weight by SDS-PAGE. Effects of GTP on PINK1 mutants, which were supplied with standard diet from larvae to adult stages, were assayed in flies aged 3-6 (I), 10-15 (II), and 20-25 (III) days. Parkinson-like phenotypes were analyzed by evaluating lifespan, dopaminergic neurons, dopamine levels, and locomotor ability. Mitochondrial function was assessed by evaluating ATP production, respirometry, and mitochondrial DNA. In addition, reactive oxygen species were measured using dihydroethidium and 2',7'-dichlorodihydrofluorescein diacetate staining. PD-related oxidative stress was simulated by paraquat and rotenone, and mitochondrial membrane potential was measured using JC-10 reagent. Protein and mRNA expression was detected by Western blot and real-time quantitative reverse transcription polymerase chain reaction, respectively.
This study demonstrates for the first time that GTP treatment delays the onset of a Parkinson-like phenotype in PINK1 Dm, including prolongation of lifespan and rescue of climbing ability, as well as rescue of the progressive loss of a cluster of dopaminergic neurons in the protocerebral posterior lateral 1 region, which was accompanied by a significant increase of dopamine content in the brain. In addition, GTP notably reduced the penetrance of abnormal wing position, indicating a strong inhibitory effect on indirect flight muscle degeneration. We further showed that GTP could promote maintenance of mitochondrial function and protect mitochondria from PD-associated oxidative stress by activating the mitochondrial unfolded protein response (UPR).
GTP protected against mitochondrial dysfunction and neurodegeneration by inducing UPR in the Dm PINK1 model of PD. Our results suggest that GTP is a promising candidate for PD, and reveal a new mechanism by which ginseng is neuroprotective.
历史文献和药理学研究表明,人参作为中国最受欢迎的草药之一,可能对帕金森病(PD)有一定的益处。
在黑腹果蝇(Dm)中的研究突出了PTEN 诱导的假定激酶 1(PINK1)缺失后线粒体功能障碍作为 PD 发病机制的核心机制。使用 PINK1 突变体 Dm,我们旨在探索人参总蛋白(GTP)对 PD 的治疗作用,并为人参的传统功效提供深入的科学解释。
我们首先使用凝胶色谱法纯化 GTP,并通过 SDS-PAGE 确认其分子量。从幼虫到成虫阶段,用标准饮食供应 GTP,检测其对 3-6 天龄(I)、10-15 天龄(II)和 20-25 天龄(III)的 PINK1 突变体的影响。通过评估寿命、多巴胺能神经元、多巴胺水平和运动能力来分析帕金森样表型。通过评估 ATP 产生、呼吸测定和线粒体 DNA 来评估线粒体功能。此外,使用二氢乙啶和 2',7'-二氯二氢荧光素二乙酸酯染色测量活性氧。通过使用百草枯和鱼藤酮模拟 PD 相关的氧化应激,并使用 JC-10 试剂测量线粒体膜电位。通过 Western blot 和实时定量逆转录聚合酶链反应分别检测蛋白质和 mRNA 表达。
本研究首次表明,GTP 处理可延迟 PINK1 Dm 帕金森样表型的发作,包括延长寿命和恢复攀爬能力,以及挽救原脑后侧外侧 1 区中一簇多巴胺能神经元的进行性丧失,同时大脑中的多巴胺含量显著增加。此外,GTP 明显降低了异常翅膀位置的发生率,表明其对间接飞行肌退化有很强的抑制作用。我们进一步表明,GTP 通过激活线粒体未折叠蛋白反应(UPR),显著促进了线粒体功能的维持,并保护线粒体免受 PD 相关的氧化应激。
GTP 通过在 Dm PINK1 PD 模型中诱导 UPR,防止了线粒体功能障碍和神经退行性变。我们的结果表明 GTP 是 PD 的一种有前途的候选药物,并揭示了人参具有神经保护作用的新机制。